LEFLUNOMIDE CH leflunomide 100mg tablet blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

leflunomide ch leflunomide 100mg tablet blister pack

southern cross pharma pty ltd - leflunomide, quantity: 100 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - treatment of active rheumatoid arthritis. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

LEFLUNOMIDE CH leflunomide 20mg tablet bottle Австралія - англійська - Department of Health (Therapeutic Goods Administration)

leflunomide ch leflunomide 20mg tablet bottle

southern cross pharma pty ltd - leflunomide, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; maize starch; povidone; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - treatment of active rheumatoid arthritis. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

LEFLUNOMIDE SZ leflunomide 100mg tablet blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

leflunomide sz leflunomide 100mg tablet blister pack

southern cross pharma pty ltd - leflunomide, quantity: 100 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - treatment of active rheumatoid arthritis. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

LEFLUNOMIDE tablet США - англійська - NLM (National Library of Medicine)

leflunomide tablet

remedyrepack inc. - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide tablets are indicated for the treatment of adults with active rheumatoid arthritis (ra). leflunomide tablets are contraindicated in: - pregnant women. leflunomide tablets may cause fetal harm. if a woman becomes pregnant while taking this drug, stop leflunomide tablets, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [ see warnings and precautions (5.1 and 5.3) and use in specific populations (8.1 )]. patients with severe hepatic impairment [ see warnings and precautions (5.2) ]. - patients with known hypersensitivity to leflunomide or any of the other components of leflunomide tablets. known reactions include anaphylaxis [ see adverse reactions (6.1) ]. - patients being treated with teriflunomide [ see drug interactions (7) ]. risk summary leflunomide tablets are contraindicated for use in pregnant women because of the potential for fetal harm. in animal reproduction studies, oral administ